SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-003673
Filing Date
2023-03-15
Accepted
2023-03-15 17:28:40
Documents
12
Period of Report
2023-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20230315.htm   iXBRL 8-K 49091
  Complete submission text file 0001564590-23-003673.txt   180032

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcon-20230315.xsd EX-101.SCH 5605
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20230315_lab.xml EX-101.LAB 19324
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20230315_pre.xml EX-101.PRE 11498
6 EXTRACTED XBRL INSTANCE DOCUMENT tcon-8k_20230315_htm.xml XML 3564
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 23736317
SIC: 2836 Biological Products, (No Diagnostic Substances)